The Recall Desk
ModerateFDA (Devices)·Z-1958-2014·Announced 2014-07-09

Focus Diagnostics Recalls Simplexa Flu A/B & RSV Direct Assay Kits

Focus Diagnostics is correcting labeling for 614 Simplexa Flu A/B & RSV Direct kits due to sporadic false signals that may increase false results.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and involves a labeling correction for a diagnostic device where the hazard is potential false results rather than direct physical injury or death.

Plain-English summary

Focus Diagnostics Inc is issuing an urgent safety notice to correct the labeling for the Simplexa Flu A/B & RSV Direct assay (Model Number MOL2650). The recall involves 614 kits distributed nationwide with expiration dates ranging from October 31, 2014, to May 31, 2015.

The recall was initiated after the company received customer complaints regarding sporadic false signals in the assays. These signals may result in a higher rate of false results due to a potential issue with the software spectral matrix and the storage of the Direct Amplification Disc.

The Simplexa Flu A/B & RSV Direct assay is intended for use on the 3M Integrated Cycler instrument for the in vitro qualitative detection and differentiation of influenza A virus, influenza B virus, and respiratory syncytial virus (RSV) RNA in nasopharyngeal swabs from human patients. The test is used as an aid in the differential diagnosis of these viral infections and is not intended to detect influenza C.

The recalled product

Product
Simplexa" Flu A/B & RSV Direct, Model Number: MOL2650. 510(k) K120413  Simplexa" Flu A/B & RSV Direct. The Focus Diagnostics Simplexa Flu A/B & RSV Direct assay is intended for use on the 3M Integrated Cycler instrument for the in vitro qualitative detection and differe
Affected units
614

Distribution

Distributed nationwide across the United States.